In a healthy human body, microbial cells outweigh human cells by a factor of ten. The study of bacteria in the human body is known as the human microbiome. These are beneficial bacteria that perform activities that no gene in human DNA does, and as a result, they serve a critical role in the human body. These microorganisms, for example, manufacture vitamins that our bodies cannot produce, break down our food, train our immune system to detect hazardous foreign bodies, and produce anti-inflammatory substances against them. The apparently endless positive capabilities of the microbial population were discovered in 2008 as part of the National Institutes of Health's Human Microbiome Project (HMP) (NIH). The HMP project seeks to define the human microbiome and investigate its function in human health and illness.
The HMP has discovered microbiome communities in a variety of human body locations, including the gastrointestinal system, skin, mouth cavity, nasal passages, and urogenital tract. The HMP initiatives are now focusing on three areas: pregnancy and preterm delivery, the development of inflammatory bowel disease, and the onset of type 2 diabetes.
Various microbiome-based products have emerged as a result of research in this sector. The worldwide human microbiome market is divided into probiotics, prebiotics, foods, medical foods, diagnostic devices, and other medications and supplements. Prebiotics are becoming more popular throughout the world as people become more aware of the product's many benefits, including improved digestion, better gut health, weight reduction assistance, and a lower risk of heart disease.
The worldwide human microbiome market is divided into therapeutic and diagnostic applications. The therapeutic use of the human microbiome is growing as research yields novel applications and uses for the human microbiome. As a result, the market is projected to shift toward therapeutic applications in the near future. Furthermore, microbiome products are seen as reasonably safe, creating a highly favorable climate for the expansion of the human microbiome sector.